Voglibose Tablets 0.3 Mg

Voglibose Tablets

Voglibose is an oral antidiabetic medication used to manage postprandial (after-meal) blood sugar levels in individuals with type 2 diabetes. It is an alpha-glucosidase inhibitor, which works by delaying the absorption of carbohydrates in the intestines, thereby preventing a spike in blood glucose levels after meals.

Composition:

• Voglibose: The active ingredient that inhibits alpha-glucosidase enzymes, reducing the rate of carbohydrate absorption.

Key Uses:

• Type 2 Diabetes Management: Voglibose is used to control postprandial blood sugar levels in individuals with type 2 diabetes, helping to manage overall blood glucose levels and reduce the risk of complications.

Administration and Dosage:

• Oral Administration: Taken orally, usually with the first bite of each main meal (three times a day).
• Dosage: The typical starting dose is 0.2 mg taken three times daily with meals. Based on the patient’s response and tolerability, the dose can be adjusted up to 0.3 mg three times daily.

Important Considerations:

• Side Effects: Common side effects include gastrointestinal symptoms such as flatulence, diarrhea, and abdominal pain. These symptoms are typically mild and may decrease over time. Serious side effects are rare but can include hypoglycemia when used in combination with other antidiabetic medications.
• Monitoring: Regular monitoring of blood sugar levels is essential to ensure the medication’s effectiveness and to avoid hypoglycemia. Periodic liver function tests may also be recommended.
• Contraindications: Not suitable for patients with inflammatory bowel disease, colonic ulceration, partial intestinal obstruction, chronic intestinal diseases associated with marked disorders of digestion and absorption, or patients with severe renal impairment.
• Drug Interactions: Voglibose can interact with other medications, including other antidiabetic drugs and digestive enzyme preparations. Inform your healthcare provider about all medications and supplements you are taking.
• Pregnancy and Breastfeeding: The safety of Voglibose during pregnancy and breastfeeding has not been established. It should only be used if clearly needed and prescribed by a healthcare provider.
• Diet and Lifestyle: Voglibose should be used as part of a comprehensive diabetes management plan that includes dietary modifications, regular physical activity, and weight management.
• Prescription Only: Available by prescription only and should be used under the supervision of a healthcare provider.

Similar Brand Names:

• Basen (Another brand name for voglibose)